Procurement Summary
Country: Brazil
Summary: Intention to Register Prices for the Future and Eventual Acquisition of Medicines (Treatment of Rare Diseases) - Intention Rp 224-2024.
Deadline: 13 Apr 2026
Posting Date: 11 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 137571072
Document Ref. No.: 92232/2024
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Intention to Register Prices for the future and eventual Acquisition of Medicines (Treatment of Rare Diseases) - Intention RP 224-2024. UASG code: 925998 Notice from: 03/11/2026 from 08:00 to 14:00 Delivery of Proposal: from 03/11/2026 at 08:00 ELEXACAFTOR, COMPOSITION ASSOCIATED WITH TEZACAFTOR AND IVACAFTOR, CONCENTRATION 100 MG + 50 MG + 75 MG AND 150 MG, ADDITIONAL TABLET A + B Quantity: 1092 BUROSUMAB, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 12 BUROSUMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 12 SELUMETINIB, CONCENTRATION 25 MG Quantity: 720 ATALUREN, CONCENTRATION 250 MG, PHARMACEUTICAL FORM GRANULES FOR ORAL SUSPENSION Quantity: 1620 LANADELUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 24 PATISIRAN, SODIUM COMPOSITION, CONCENTRATION 2 MG/ML, INJECTABLE PHARMACEUTICAL FORM Quantity: 24 INOTERSENE, NONADECASODIC COMPOSITION, CONCENTRATION 200 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS FILLED SYRINGE Quantity: 1 ESTRASE, HUMAN C1 ESTRASE INHIBITOR COMPOSITION, CONCENTRATION 500 IU, PHARMACEUTICAL FORM* LYOPHIL POWDER FOR INJECTION Quantity: 24
Documents
Tender Notice